Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 1/20 | 0.81 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.69 |
| ▸ | MAPT | P10636 | 1/20 | 0.69 |
| ▸ | THRB | P10828 | 1/20 | 0.69 |
| ▸ | CNR1 | P21554 | 1/20 | 0.69 |
| ▸ | DGKA | P23743 | 2/20 | 0.64 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.63 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.61 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.61 |
| ▸ | TSHR | P16473 | 2/20 | 0.61 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.61 |
| ▸ | FAAH | O00519 | 2/20 | 0.60 |
| ▸ | F7 | P08709 | 3/20 | 0.59 |
| ▸ | F3 | P13726 | 3/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.59 |
| ▸ | PPARG | P37231 | 2/20 | 0.59 |
| ▸ | PPARD | Q03181 | 2/20 | 0.59 |
| ▸ | PPARA | Q07869 | 2/20 | 0.59 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7639501 | 0.95 | MGLL (0.77) | MGLLALDH1A1MAPTTHRBCNR1 | |
| Ethylene Glycol SCHEMBL3286075 | 0.95 | MGLL (0.72) | MGLLALDH1A1MAPTTHRBCNR1 | |
| Ethylene Glycol SCHEMBL19064550 | 0.95 | MGLL (0.72) | MGLLALDH1A1MAPTTHRBCNR1 | |
| SCHEMBL3280959 | 0.94 | MGLL (0.91) | MGLLALDH1A1MAPTTHRBCNR1 | |
| SCHEMBL17685834 | 0.94 | MGLL (0.91) | MGLLALDH1A1MAPTTHRBCNR1 | |
| SCHEMBL28405410 | 0.94 | MGLL (0.80) | MGLLALDH1A1MAPTTHRBCNR1 | |
| SCHEMBL3660036 | 0.93 | MGLL (0.78) | MGLLALDH1A1MAPTTHRBCNR1 | |
| SCHEMBL17558128 | 0.93 | MGLL (0.78) | MGLLALDH1A1MAPTTHRBCNR1 | |
| SCHEMBL29513053 | 0.92 | MGLL (0.94) | MGLLALDH1A1MAPTTHRBCNR1 | |
| SCHEMBL10716785 | 0.92 | MGLL (0.77) | MGLLALDH1A1MAPTTHRBCNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115844832-A | Self-assembled nanoparticles of two small-molecule prodrugs capable of adjusting proportion and synchronously releasing two proto-drugs, preparation method and application | 盐城工学院 | 2023-03-28 | — | — | CN | claimed |
| CN-104342090-A | Lubricant for drilling fluid, and application thereof | CHINA PETROLEUM & CHEMICAL | 2015-02-11 | — | — | CN | claimed |
| CN-115624631-B | Bufotalin prodrug self-assembled nanoparticle and preparation method and application thereof | 盐城工学院 | 2024-10-01 | — | — | CN | disclosed |
| CN-109988349-B | Rubber composition for tire outer layer and pneumatic tire | 住友橡胶工业株式会社 | 2022-11-08 | — | — | CN | disclosed |
| CN-109549927-B | Solid solution compositions and their use in cardiovascular disease | 因佛斯特医疗有限公司 | 2022-03-29 | — | — | CN | disclosed |
| US-20210252024-A1 | Cancer Drug and Uses | HEALTH CLINICS LIMITED (GB) | 2021-08-19 | — | — | US | disclosed |
| CN-104981253-B | Solid solution composition and its purposes in chronic inflammation | 因佛斯特医疗有限公司 | 2019-05-10 | — | — | CN | disclosed |
| CN-109549927-A | Solid solution composition and its purposes in cardiovascular disease | 因佛斯特医疗有限公司 | 2019-04-02 | — | — | CN | disclosed |
| CN-105007947-B | solid solution compositions and their use in cardiovascular disease | 因佛斯特医疗有限公司 | 2019-02-15 | — | — | CN | disclosed |
| US-10188668-B2 | Cancer drug and uses | HEALTH CLINICS LIMITED (GB) | 2019-01-29 | — | — | US | disclosed |
| CN-104968368-B | Solid solution compositions and their use in severe pain | 因佛斯特医疗有限公司 | 2018-05-04 | — | — | CN | disclosed |
| CN-104981253-A | Solid solution compositions and use in chronic inflammation | BIOCOPEA LTD | 2015-10-14 | — | — | CN | disclosed |
| CN-104968368-A | Solid solution compositions and their use in severe pain | INFIRST HEALTHCARE LTD | 2015-10-07 | — | — | CN | disclosed |
| CN-104968330-A | Compositions and methods for treating severe pain | INFIRST HEALTHCARE LTD | 2015-10-07 | — | — | CN | disclosed |
| CN-104342090-A | Lubricant for drilling fluid, and application thereof | CHINA PETROLEUM & CHEMICAL | 2015-02-11 | — | — | CN | disclosed |
| US-7705084-B2 | Water borne film-forming compositions | THE CURATORS OF THE UNIVERSITY OF MISSOURI (US) | 2010-04-27 | — | — | US | disclosed |
| US-20070093579-A1 | Water Borne Film-Forming Compositions | THE CURATORS OF THE UNIVERSITY OF MISSOURI (US) | 2007-04-26 | — | — | US | disclosed |
| US-7160945-B1 | Water borne film-forming compositions | THE CURATORS OF THE UNIVERSITY OF MISSOURI (US) | 2007-01-09 | — | — | US | disclosed |
| US-20040039095-A1 | Water borne film-forming compositions | THE CURATORS OF THE UNIVERSITY OF MISSOURI | 2004-02-26 | — | — | US | disclosed |
| EP-1169397-B1 | WATER BORNE FILM-FORMING COMPOSITIONS | UNIV MISSOURI (US) | 2003-07-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10188668-B2 | Cancer drug and uses | NPC1L1, PCK2, NPC1 | MGLL 120/4885ALDH1A1 1275/4885MAPT 716/4885 |
| US-20210252024-A1 | Cancer Drug and Uses | NPC1L1, PCK2, NPC1 | MGLL 120/4885ALDH1A1 1275/4885MAPT 716/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.